DataExpo GAKG DeepReport Navigation

Copyright©2015-2024 Acemap, Inc. Shanghai Jiao Tong University. All rights reserved.

沪ICP备18028330号

NB

Nathalie Bourgès‐Abella

Author Statistics

Papers

Citation

H-Index

i-10 index

Research Trends

Author Order

Document Type

Co-Authors

Fanny Granat

École Nationale Vétérinaire de Toulouse

Jean‐Emmanuel Sarry

Centre de Recherche en Cancérologie de Toulouse

Ambrine Sahal

Centre de Recherche en Cancérologie de Toulouse

Rémy Castellano

Aix-Marseille Université

Anne S. Dejean

Université Toulouse III - Paul Sabatier

Federico Simonetta

University of Geneva

Léa Goupille

Centre de Recherche en Cancérologie de Toulouse

Armelle Goubard

Aix-Marseille Université

Olivier Kosmider

Assistance Publique – Hôpitaux de Paris

Paolo Gallipoli

Queen Mary University of London

Cooperative Institutions

Inserm

Centre National de la Recherche Scientifique

Université de Toulouse

École Nationale Vétérinaire de Toulouse

Université Toulouse III - Paul Sabatier

Université Paris Cité

Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement

Sorbonne Paris Cité

La Ligue Contre le Cancer

Sorbonne Université

Author Statistics

Papers

Citation

H-Index

i-10 index

Research Field

Supplementary Table S15 from C/EBPα Confers Dependence to Fatty Acid Anabolic Pathways and Vulnerability to Lipid Oxidative Stress–Induced Ferroptosis in <i>FLT3</i>-Mutant Leukemia

Marie Sabatier Rudy Birsen Laura Lauture Sarah Mouche Paolo Angelino

<p>Table S15: Relative quantification by lipid class</p>

Vulnerability

10.1158/2159-8290.23618446.v1

Cite

Citations (0)

Supplementary Table S1 from C/EBPα Confers Dependence to Fatty Acid Anabolic Pathways and Vulnerability to Lipid Oxidative Stress–Induced Ferroptosis in <i>FLT3</i>-Mutant Leukemia

Marie Sabatier Rudy Birsen Laura Lauture Sarah Mouche Paolo Angelino

<p>Table S1: Transcriptome analysis of FLT3-ITD cell lines after FLT3 inhbition</p>

10.1158/2159-8290.23641329

Cite

Citations (0)

Supplementary Table S7 from C/EBPα Confers Dependence to Fatty Acid Anabolic Pathways and Vulnerability to Lipid Oxidative Stress–Induced Ferroptosis in <i>FLT3</i>-Mutant Leukemia

Marie Sabatier Rudy Birsen Laura Lauture Sarah Mouche Paolo Angelino

<p>Table S7: Transcriptomics analysis of shCEBPA#2 versus shCTL</p>

10.1158/2159-8290.23641290.v1

Cite

Citations (0)

Supplementary Table S11 from C/EBPα Confers Dependence to Fatty Acid Anabolic Pathways and Vulnerability to Lipid Oxidative Stress–Induced Ferroptosis in <i>FLT3</i>-Mutant Leukemia

Marie Sabatier Rudy Birsen Laura Lauture Sarah Mouche Paolo Angelino

<p>Table S11</p>

Table (database)

10.1158/2159-8290.23579637

Cite

Citations (0)

Supplementary Table S6 from C/EBPα Confers Dependence to Fatty Acid Anabolic Pathways and Vulnerability to Lipid Oxidative Stress–Induced Ferroptosis in <i>FLT3</i>-Mutant Leukemia

Marie Sabatier Rudy Birsen Laura Lauture Sarah Mouche Paolo Angelino

<p>Table S6: Proteomic analysis of FLT3-ITD AML cell lines treated with vehicle or QUIZ</p>

10.1158/2159-8290.23579607.v1

Cite

Citations (0)

Supplementary Table S11 from C/EBPα Confers Dependence to Fatty Acid Anabolic Pathways and Vulnerability to Lipid Oxidative Stress–Induced Ferroptosis in <i>FLT3</i>-Mutant Leukemia

Marie Sabatier Rudy Birsen Laura Lauture Sarah Mouche Paolo Angelino

<p>Table S11</p>

Vulnerability

10.1158/2159-8290.23579637.v1

Cite

Citations (0)

Supplementary Table S10 from C/EBPα Confers Dependence to Fatty Acid Anabolic Pathways and Vulnerability to Lipid Oxidative Stress–Induced Ferroptosis in <i>FLT3</i>-Mutant Leukemia

Marie Sabatier Rudy Birsen Laura Lauture Sarah Mouche Paolo Angelino

<p>Table S10: EnrichR analysis of CEBPA_UP signature</p>

CEBPA

10.1158/2159-8290.23579640.v1

Cite

Citations (0)

Supplementary Table S5 from C/EBPα Confers Dependence to Fatty Acid Anabolic Pathways and Vulnerability to Lipid Oxidative Stress–Induced Ferroptosis in <i>FLT3</i>-Mutant Leukemia

Marie Sabatier Rudy Birsen Laura Lauture Sarah Mouche Paolo Angelino

<p>Table S5: GSEA results in FLT3-ITD PDX AML cells in vivo-treated with GILT or Veh.</p>

10.1158/2159-8290.23579610.v1

Cite

Citations (0)

Supplementary Table S4 from C/EBPα Confers Dependence to Fatty Acid Anabolic Pathways and Vulnerability to Lipid Oxidative Stress–Induced Ferroptosis in <i>FLT3</i>-Mutant Leukemia

Marie Sabatier Rudy Birsen Laura Lauture Sarah Mouche Paolo Angelino

<p>Table S4: GSEA results in FLT3-ITD PDX AML cells ex vivo-treated with QUIZ or Veh.</p>

Ex vivo

10.1158/2159-8290.23579613.v1

Cite

Citations (0)

Adverse Haematological Effects of Vinblastine, Prednisolone and Cimetidine Treatment: a Retrospective Study in Fourteen Dogs with Mast Cell Tumours

Journal of Veterinary Medicine Series A (2005)

Catherine Trumel Nathalie Bourgès‐Abella C Touron D. Lanoré Anne Geffré

Vinblastine toxicity is poorly documented in dogs. The aim of this study was to investigate the haematological alterations in dogs treated with vinblastine and prednisolone. Fourteen dogs with mast cell tumours (MCT) were selected on at least one of the following criteria: lymph node infiltration, surgical margin infiltration, grade II MCTs with Ki-67 >10%, and grade III MCTs. Starting 15 days after surgery, the dogs were given vinblastine (2 mg/m2 i.v. four times weekly, then twice monthly for 2 months) and prednisolone (2 mg/kg/day p.o.). An EDTA blood sample was collected weekly for complete blood count (CBC). A total of 98 doses of vinblastine were given to the 14 dogs and 114 CBC were performed. Abnormal haematological findings were observed in 12 CBCs from five dogs, which represent a prevalence of 20% of the total CBCs performed in these animals. The most prevalent abnormal finding was thrombopenia (9/12) most often with grade I toxicity (6/9). In conclusion, the risk of occurrence of adverse haematological effects resulting from vinblastine-prednisolone treatment seems limited in dogs with MCT and it should not be overestimated.

Prednisolone

Complete blood count

Blood count

10.1111/j.1439-0442.2005.00725.x

Cite

Citations (14)

More pages